Pfizer vaccine leads to off the scale immune response which works on Brazil variant
Researchers say the vaccine protects against the Kent and Brazilian variant
The Pfizer-BioNTech Covid-19 vaccine is said to produce an off the scale immune response
A tumultuous time for our city - sign up for the Liverpool Echo newsletter so you don t miss the big storiesInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
The Pfizer Covid-19 vaccine appears to offer 100% protection against the South African variant and most likely protects against the Brazilian variant, two new studies suggest.
Research published by Pfizer/BioNTech on Thursday offers the first in-human evidence of how the vaccine protects against the South African variant that has been worrying scientists.
The pharmaceutical giant said its findings show the vaccine is 100% effective in preventing Covid-19 cases in South Africa – where the South African variant is now common.
(PA Graphics)
Among 800 people in South Africa, nine cases of the South African variant of Covid were observed – all in the group not given the vaccine.